Max Healthcare Institute Limited (NSE:MAXHEALTH)
1,213.80
+50.80 (4.37%)
Jun 20, 2025, 3:30 PM IST
Max Healthcare Institute Revenue
In the fiscal year ending March 31, 2025, Max Healthcare Institute had annual revenue of 70.28B INR with 30.01% growth. Max Healthcare Institute had revenue of 19.10B in the quarter ending March 31, 2025, with 34.21% growth.
Revenue
70.28B
Revenue Growth
+30.01%
P/S Ratio
16.79
Revenue / Employee
3.60M
Employees
19,500
Market Cap
1,179.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 70.28B | 16.22B | 30.01% |
Mar 31, 2024 | 54.06B | 8.43B | 18.49% |
Mar 31, 2023 | 45.63B | 6.26B | 15.90% |
Mar 31, 2022 | 39.37B | 14.29B | 56.96% |
Mar 31, 2021 | 25.08B | 14.49B | 136.82% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Mankind Pharma | 122.07B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |
Max Healthcare Institute News
- 4 days ago - Stocks hitting 52-week highs today, June 16: Bharat Electronics, Laurus Labs, Max Healthcare, JK Cement and more - Business Upturn
- 9 days ago - Max Healthcare shares jump 2% after Jefferies maintains ‘Buy’ call with target price of Rs 1,400 - Business Upturn
- 9 days ago - Stocks to watch on June 12: Tata Comm, Max Health, Dr Reddy’s, HDFC Life, PayTM in focus on brokerage views - Business Upturn
- 9 days ago - Jefferies maintains ‘Buy’ call on Max Healthcare; sees 75% bed capacity expansion as key growth driver - Business Upturn
- 4 weeks ago - Brokerages on Max Healthcare stock: Buy, sell or hold? Check UBS, HSBC calls - Business Upturn
- 4 weeks ago - HSBC maintains ‘Hold’ on Max Healthcare; sees 7.8% downside amid limited re-rating scope - Business Upturn
- 4 weeks ago - UBS maintains ‘Buy’ on Max Healthcare, raises target price; sees 18% upside amid expansion-led growth - Business Upturn
- 4 weeks ago - Stocks to watch on news today: Dr Reddy’s, Sun Pharma, BEL, JSW Steel, NBCC, Max Healthcare, PNC Infra in focus - Business Upturn